SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?


To: Ace who wrote (9379)6/1/1998 9:56:00 AM
From: Step1  Read Replies (1) | Respond to of 14328
 
I was just a bit too slow...

After reviewing charts over the weekend I thought TRIBY was showing such a perfect wedge, it had to break out one way or another. WE had a pretty solid floor at two so the upside potential was great and now we are seeing it moving... hey hey. I will not chase it but rather hold on to my existing position and put my foot on the desk and smile.

This company can get its tests through the FDA so that is a nice sign..

sg



To: Ace who wrote (9379)6/1/1998 10:11:00 AM
From: Keiko  Respond to of 14328
 
Dr Urinovitz flying high !

CALY......7 1/8 ...up 3/4.......news out

biz.yahoo.com



To: Ace who wrote (9379)6/1/1998 10:35:00 AM
From: Hope  Read Replies (1) | Respond to of 14328
 
FROM BRIEFING.COM ! ! !

10:20 ET Trinity Biotech plc (TRIBY) 2 15/32 +3/32 (+4%): Company announced that it has
received FDA marketing clearance of two new markers that detect the presence of the Epstein Barr
Virus (EBV), the cause of mono and chronic fatigue syndrome. The products will be distributed in
the U.S. through Wampole Laboratories, a division of Carter-Wallace. Volume 186K.